We have previously shown that newborn infants may develop prolonged muscle weakness following treatment with neuromuscular blocking agents(Pediatr Res 1996:211A). One possible cause is a change in the nicotinic acetylcholine muscle receptors.

Objective: To immunohistochemically assess diaphragm muscle nicotinic acetylcholine receptors.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD